ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Institute Of Medicine: External Experts Should Vet Large Projects, Report Says.

June 20, 2003

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

Breast Removal Reduces Risk Of Cancer In BRCA Carriers

October 26, 2001

Letter to the Editor: Expanding the Horizons Of Proton Beam Therapy

August 1, 2014

BSA Approves Concept For Ovarian Cancer SPORE Grant

June 26, 1998